N/A N=40 Randomized Single-blind Treatment

Guided Group Telehealth to Deliver Evidence-based Therapeutic Care to Black College Students

Anxiety Depression

Bottom Line

View on ClinicalTrials.gov: NCT07237217 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Feb 2026

Primary outcome: Primary: Engagement (8-item Scale) — 3.90; 4.62 Mean engagement score

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Cognitive Behavioral Therapy (CBT) Coping Skills Training (Behavioral)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Dr. Veronica Tetterton
Primary completion: Aug 2025

Outcome Measures

Outcome	Result	p-value
PRIMARY Engagement (8-item Scale)	3.74; 4.79	—
PRIMARY Engagement (8-item Scale)	3.74; 4.79	—
PRIMARY Engagement (8-item Scale)	3.74; 4.79	—
PRIMARY Anxiety Symptoms (GAD-7)	10.01; 8.96	—
PRIMARY Anxiety Symptoms (GAD-7)	10.01; 8.96	—
PRIMARY Anxiety Symptoms (GAD-7)	10.01; 8.96	—
PRIMARY Anxiety Symptoms (GAD-7)	10.01; 8.96	—
PRIMARY Depressive Symptoms (PHQ-9)	15.12; 14.49	—
PRIMARY Depressive Symptoms (PHQ-9)	15.12; 14.49	—
PRIMARY Depressive Symptoms (PHQ-9)	15.12; 14.49	—
SECONDARY Completion Rate	15; 17	—
SECONDARY User Feedback Sentiment	0.39; 0.393	—
SECONDARY User Feedback Sentiment	0.39; 0.393	—
SECONDARY User Feedback Sentiment	0.39; 0.393	—

Summary

The goal of this study is to address the mental health crisis among college students by creating a promising solution for group teletherapy, which is equivalent to individual teletherapy in terms of treatment outcomes.The main question it aims to answer is: if participants' outcome measures in TheraGroup are in line with participants' outcome measures in individual therapy. The goal of the current SBIR is to test TheraGroup, the first large scale virtual group platform for evidenced-based mental health therapy. The TheraGroup application addresses the market surge in the demand for care and the shortage of mental health professionals as it represents an economically viable treatment alternative to individual teletherapy.

Eligibility Criteria

Inclusion Criteria

Individuals at PVAMU 18 years and older

Exclusion Criteria

Individuals younger than 18 years of age will be excluded from the clinical trial.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT07237217). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.